Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Icogen's Chemokine Research Receives $1M SBIR Award

Feb. 6, 2003

By Aaron Lorenzo

TransTech Translates Progress Into $24.5M Secured Investment

Feb. 5, 2003

By Aaron Lorenzo

MaxCyte, Northern Therapeutics Enter Gene Therapy Delivery Deal

Feb. 5, 2003

By Aaron Lorenzo

MaxCyte, Northern Therapeutics Enter Gene Therapy Delivery Deal

Feb. 5, 2003

By Aaron Lorenzo

TransTech Translates Progress Into $24.5M Secured Investment

Feb. 5, 2003

By Aaron Lorenzo

Abgenix, Chugai Collaborate On Human Antibody Therapies

Feb. 4, 2003

By Aaron Lorenzo

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Feb. 4, 2003

By Aaron Lorenzo

Abgenix, Chugai Collaborate On Human Antibody Therapies

Feb. 4, 2003

By Aaron Lorenzo

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Feb. 4, 2003

By Aaron Lorenzo

Texas Biotechnology Regaining Rights To PAH Drug From ICOS

Feb. 3, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 24, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.